1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one
C24H23N5O2 — CID 177171457
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one
1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one (PubChem CID 177171457) has the molecular formula C24H23N5O2 and a molecular weight of 413.48 g/mol. Its IUPAC name is 1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one.
Molecular Properties
| Compound Name | 1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one |
|---|---|
| PubChem CID | 177171457 |
| Molecular Formula | C24H23N5O2 |
| Molecular Weight | 413.48 g/mol |
| Exact Mass | 413.19 |
| IUPAC Name | 1-[5-[2-(6-methyl-3-pyridinyl)-1-benzofuran-5-yl]-3,6-dihydro-2H-pyridin-1-yl]-3-(triazol-1-yl)propan-1-one |
| SMILES | Cc1ccc(-c2cc3cc(C4=CCCN(C(=O)CCn5ccnn5)C4)ccc3o2)cn1 |
| InChI | InChI=1S/C24H23N5O2/c1-17-4-5-19(15-25-17)23-14-21-13-18(6-7-22(21)31-23)20-3-2-10-28(16-20)24(30)8-11-29-12-9-26-27-29/h3-7,9,12-15H,2,8,10-11,16H2,1H3 |
| InChIKey | FZOYQBWMLCLBCE-UHFFFAOYSA-N |
| XLogP | 4.10 |
| TPSA | 77.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.48 |
| LogP ≤ 5 | 4.10 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177171457 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.